Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR3 | P49682 | 8/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3401897 | 0.82 | TP53 (0.37) | CXCR3HRH3HTR1AADRA1DADRA1A | |
| SCHEMBL3401905 | 0.82 | TP53 (0.37) | CXCR3HRH3HTR1AADRA1DADRA1A | |
| SCHEMBL4177092 | 0.67 | ADRA1D (0.50) | HRH3HTR1AADRA1DADRA1AADRA1B | |
| Hydrochloric Acid SCHEMBL4172845 | 0.66 | ADRA1D (0.49) | HRH3HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL14818777 | 0.65 | GRIN2D (0.49) | HRH3HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL14803708 | 0.64 | ADRB1 (0.44) | HRH3HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL3401669 | 0.64 | PTPN11 (0.47) | — | |
| SCHEMBL3401673 | 0.64 | PTPN11 (0.47) | — | |
| SCHEMBL4291633 | 0.62 | ADRA1D (0.49) | HRH3HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL30417113 | 0.62 | HSD11B1 (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2247591-A1 | PYRROLO [2, 3-D]PYRIDINES AND USE THEREOF AS TYROSINE KINASE INHIBITORS | Novartis AG (CH) | 2010-11-10 | — | — | EP | disclosed |
| WO-2009098236-A1 | PYRROLO [2, 3-D] PYRIDINES AND USE THEREOF AS TYROSINE KINASE INHIBITORS | NOVARTIS AG (CH) | 2009-08-13 | — | — | WO | disclosed |